Cannara Biotech Inc. (LOVE.TO)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 3 | 17 | 36 | 57 | 82 | 107 | 118 | 123 |
| Operating profit | CAD m | 22 | - | ||||||
| Net profit | CAD m | -14 | -2 | 2 | 7 | 6 | 13 | 11 | 11 |
| EPS reported | CAD | 0.14 | 0.11 | ||||||
| Operating cashflow per share | CAD | 0.21 | 0.19 | ||||||
| Capex per share | CAD | 0.07 | 0.14 | ||||||
| FCF per share | CAD | 0.15 | 0.05 | ||||||
| Free cash flow | CAD m | 14 | 5 | ||||||
| Net debt | CAD m | 27 | 15 | ||||||
| Book value equity | CAD m | 102 | 126 | ||||||
| Book value per share | CAD | 1.11 | 1.25 | ||||||
| Number of shares | m | 92.37 | 100.52 | ||||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 17.75 | ||||||
| P/B LTM | x | 1.63 | 1.32 | ||||||
| P/S LTM | x | 1.55 | 1.41 | ||||||
| P/FCF LTM | x | 12.18 | 35.10 | ||||||
| EV/EBITDA LTM | x | 6.87 | 13.82 | ||||||
| EV/Sales LTM | x | 1.82 | 1.79 | ||||||
| Earnings Yield LTM | % | +7.78% | +5.63% | ||||||
| FCF Yield | % | +8.21% | +2.85% | ||||||
| Quality | |||||||||
| ROE | % | +12.79% | +9.45% | ||||||
| ROIC | % | +10.86% | +0.05% | ||||||
| Operating margin | % | +20.68% | +0.10% | ||||||
| Gross margin | % | +44.00% | +26.30% | ||||||
| FCF/Sales | % | +12.72% | +4.02% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +98.58% | +56.03% | ||||||
| Sales Growth YoY | % | +31.28% | +44.05% | ||||||
| Net Income Growth YoY | % | +103.09% | +68.65% | ||||||
| FCF Growth | % | +324.86% | +47.37% | ||||||
| Operating Profit Growth | % | +120.24% | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.33 | 0.13 | ||||||
| Net Debt/EBITDA | x | 0.97 | 1.08 | ||||||
| EBIT/Net interest | x | 5.10 | 0.04 | ||||||
| Net debt/market cap | % | +24.50% | +18.91% | ||||||
| Net debt/Equity | x | 0.26 | 0.12 | ||||||
| Gross debt/equity | x | 0.41 | 0.29 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free